DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment
A phase 3 trial of Atezolizumab, Carboplatin, Etoposide in small-cell lung cancer, run by Boehringer Ingelheim, now recruiting.
Overview
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy is a phase 3 interventional study registered as NCT07472517 by Boehringer Ingelheim, with 670 participants planned, started 2026-04-13 and due to reach its primary completion in 2028-09-09. Interventions recorded: obrixtamig, atezolizumab, carboplatin, etoposide. Conditions listed: Small Cell Lung Cancer (SCLC), Extensive-stage Small Cell Lung Cancer (ES-SCLC). No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialDAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
Shares Boehringer Ingelheim, Etoposide, Carboplatin.
- TrialA Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
Shares Etoposide, Atezolizumab, Carboplatin, Small-cell lung cancer.
- TrialSafety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Shares Etoposide, Atezolizumab, Carboplatin, Small-cell lung cancer.
- TrialPembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)
Shares Etoposide, Atezolizumab, Carboplatin, Small-cell lung cancer.
- TrialBL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
Shares Etoposide, Atezolizumab, Carboplatin, Small-cell lung cancer.
- TrialStudy of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer
Shares Etoposide, Atezolizumab, Carboplatin, Small-cell lung cancer.
- TrialDAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
- TrialPharmacogenomics ANDA SNP Clinical Study - Etoposide and Single Nucleotide Polymorphisms
Shares Etoposide, Small-cell lung cancer.